Novo Nordisk Investor Presentation - First Nine Months of 2016

Investor presentation First nine months of 2016 Slide 24 Novo Nordisk works with four strategic focus areas based on five core capabilities STRATEGIC PRIORITIES CORE CAPABILITIES Expand leadership in DIABETES Engineering, formulating, developing and delivering protein-based treatments Deep disease understanding Efficient large-scale production of proteins Pursue leadership in OBESITY Pursue leadership in HAEMOPHILIA Expand leadership in GROWTH DISORDERS Novo Nordisk Way changing diabetes Planning and executing global launches of new products Building and maintaining a leading position in emerging markets Driving change to defeat diabetes and other serious chronic conditions novo nordisk

View entire presentation